Calumet (NASDAQ:CLMT) Director Daniel Sajkowski Sells 3,310 Shares

Key Points

  • Director Daniel Sajkowski sold 3,310 shares on April 1 at an average price of $34.46 for $114,062.60, trimming his stake by 3.88% to about 81,958 shares.
  • Calumet beat quarterly EPS estimates (reported -$0.43 vs. -$0.67 expected) with revenue of $1.04B (+9.4% YoY), but an unplanned maintenance at its Shreveport plant could reduce near-term throughput and raise costs.
  • Analyst views are mixed: the consensus is a Hold with a $30.17 target while HC Wainwright upgraded forecasts and set a $60 target; the stock trades near its 52-week high and carries a $3.04B market cap.

Calumet, Inc. (NASDAQ:CLMT - Get Free Report) Director Daniel Sajkowski sold 3,310 shares of Calumet stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $34.46, for a total transaction of $114,062.60. Following the completion of the sale, the director directly owned 81,958 shares of the company's stock, valued at $2,824,272.68. The trade was a 3.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Calumet Stock Up 1.4%

Shares of Calumet stock opened at $35.06 on Friday. Calumet, Inc. has a fifty-two week low of $7.68 and a fifty-two week high of $36.94. The business's fifty day moving average is $27.92 and its two-hundred day moving average is $22.30. The firm has a market cap of $3.04 billion, a PE ratio of -89.90 and a beta of 0.86.

Calumet (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings data on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, beating analysts' consensus estimates of ($0.67) by $0.24. The business had revenue of $1.04 billion during the quarter, compared to analysts' expectations of $1.04 billion. During the same period in the prior year, the firm earned ($0.47) EPS. Calumet's revenue for the quarter was up 9.4% on a year-over-year basis. Equities research analysts anticipate that Calumet, Inc. will post -3.02 EPS for the current year.

Key Calumet News




Here are the key news stories impacting Calumet this week:

  • Positive Sentiment: HC Wainwright raised multiple 2026–2027 EPS estimates and reiterated a "Buy" rating with a $60 price target, shifting FY2027 from a loss forecast to a positive $1.07 EPS — a meaningful expectation upgrade that supports upside in the stock. Article Title
  • Positive Sentiment: Brokerage and media coverage highlights (e.g., Zacks) flagged the recent surge and the upward trend in earnings revisions, which can attract momentum buying and higher intraday volume. Article Title
  • Neutral Sentiment: Director Daniel J. Sajkowski disclosed a sale of 3,310 shares at ~$34.46 on April 1; the sale is modest relative to his remaining ~81,958 shares but may draw short-term attention from traders tracking insider activity. SEC Form 4
  • Negative Sentiment: Operational headwind: Calumet disclosed unplanned maintenance at its Shreveport plant after detecting organic chlorides in feedstock tanks, which could reduce near-term throughput and raise maintenance costs or downtime risk until resolved. PR Newswire

Institutional Investors Weigh In On Calumet

Several institutional investors have recently bought and sold shares of CLMT. Legal & General Group Plc raised its stake in shares of Calumet by 36.6% in the 2nd quarter. Legal & General Group Plc now owns 72,143 shares of the oil and gas company's stock valued at $1,137,000 after acquiring an additional 19,322 shares during the period. Rhumbline Advisers purchased a new position in Calumet in the second quarter valued at about $1,610,000. Ameritas Investment Partners Inc. purchased a new position in Calumet in the second quarter valued at about $111,000. XTX Topco Ltd acquired a new position in shares of Calumet during the second quarter worth about $468,000. Finally, J.W. Cole Advisors Inc. boosted its position in shares of Calumet by 32.0% in the second quarter. J.W. Cole Advisors Inc. now owns 23,289 shares of the oil and gas company's stock worth $367,000 after buying an additional 5,650 shares during the period. 34.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. TD Cowen boosted their target price on shares of Calumet from $19.00 to $25.00 and gave the company a "hold" rating in a report on Thursday, March 5th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Calumet in a report on Monday, December 29th. UBS Group reissued a "neutral" rating and set a $26.00 price objective on shares of Calumet in a research note on Friday, February 13th. The Goldman Sachs Group increased their target price on Calumet from $24.00 to $34.00 and gave the stock a "buy" rating in a research report on Thursday, March 12th. Finally, Wall Street Zen downgraded Calumet from a "buy" rating to a "hold" rating in a research report on Sunday, December 14th. Four research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $30.17.

Get Our Latest Research Report on Calumet

About Calumet

(Get Free Report)

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet's product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.

See Also

Insider Buying and Selling by Quarter for Calumet (NASDAQ:CLMT)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Calumet?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Calumet and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles